Park Place Capital’s Novartis NVS Stock Holding History

Park Place Capital’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$29.3K	Hold	187	–	–	﹤0.01%	550
2026 Q1	$28.6K	Hold	187	–	–	0.01%	439
2025 Q4	$25.8K	Buy	187 +35	+23%	+$4.58K	0.01%	424
2025 Q3	$19.5K	Hold	152	–	–	﹤0.01%	459
2025 Q2	$18.7K	Hold	152	–	–	﹤0.01%	486
2025 Q1	$16.9K	Hold	152	–	–	﹤0.01%	491
2024 Q4	$14.8K	Hold	152	–	–	﹤0.01%	523
2024 Q3	$17.5K	Sell	152 -642	-81%	-$72.8K	0.01%	532
2024 Q2	$84.5K	Sell	794 -879	-53%	-$88.2K	0.03%	297
2024 Q1	$162K	Sell	1,673 -785	-32%	-$80.5K	0.06%	256
2023 Q4	$248K	Sell	2,458 -1,112	-31%	-$107K	0.1%	197
2023 Q3	$364K	Buy	3,570 +13	+0.4%	+$1.32K	0.11%	170
2023 Q2	$359K	Sell	3,557 -498	-12%	-$49.8K	0.1%	178
2023 Q1	$373K	Buy	4,055 +106	+3%	+$9.26K	0.1%	175
2022 Q4	$358K	Buy	+3,949	New	+$333K	0.1%	175

Other funds holding NVS

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Park Place Capital's NVS Position: Q2 2026 in Review

Park Place Capital held its Novartis (NVS) position steady in Q2 2026 at 187 shares worth $29.3K. The position accounts for ﹤0.01% of the portfolio, ranked #550.

Park Place Capital first reported a position in NVS in Q4 2022 and has held it in 15 quarters since. The position peaked at $373K in Q1 2023. 1,620 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

Park Place Capital held 187 shares of Novartis worth $29.3K as of Q2 2026.
Park Place Capital left its Novartis share count unchanged in Q2 2026.
Novartis made up ﹤0.01% of Park Place Capital's portfolio in Q2 2026, its #550 holding.
Park Place Capital first reported a position in Novartis in Q4 2022 and has held it in 15 quarters since.
Park Place Capital's Novartis position peaked at $373K in Q1 2023.
1,620 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Park Place Capital's 13F filing for Q2 2026, filed 14 Aug 2026.